Send to

Choose Destination
See comment in PubMed Commons below
Clin Pharmacol Ther. 2012 Mar;91(3):438-41. doi: 10.1038/clpt.2011.250. Epub 2012 Feb 8.

Effect of the market withdrawal of carisoprodol on use of other prescribed drugs with abuse potential.

Author information

  • 1Department of Pharmacoepidemiology, Norwegian Institute of Public Health, Oslo, Norway.


Carisoprodol, a centrally acting muscle relaxant indicated for acute lower back pain, has been available in Europe and the United States since 1959. Studies indicating increased risk of abuse or addiction led to withdrawal of the drug from the market in Norway and other EU countries in 2008. In this nationwide longitudinal prescription study of 53,116 individuals in Norway, previous users of carisoprodol switched, to a limited extent, to other prescribed drugs with abuse potential after the withdrawal.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Write to the Help Desk